Is BrightSpring Health Services, Inc. overvalued or undervalued?

As of 17 October 2025, the valuation grade for BrightSpring Health Services, Inc. moved from expensive to attractive, indicating a shift towards being undervalued. The company appears undervalued based on its metrics, with a P/E ratio of 37, a Price to Book Value of 2.49, and an EV to EBITDA of 12.65. Compared to peers, BrightSpring's P/E ratio of 37.784 is slightly higher than the industry average, but its PEG ratio of 0.12 suggests strong growth potential relative to its price.
In terms of peer comparison, BrightSpring Health Services is positioned against a competitor with a P/E of 37.784 and an EV to EBITDA of 13.2063, indicating that while it may be slightly more expensive on a P/E basis, its growth prospects are more favorable. The company's recent stock performance has significantly outpaced the S&P 500, with a year-to-date return of 74.57% compared to the S&P 500's 13.30%, reinforcing the attractiveness of its current valuation.